Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 4 Mar 2010 |
| Updated company calendar 2010 | 1 Mar 2010 |
| To the shareholders of Novozymes A/S | 4 Feb 2010 |
| CORRECTION: The Novozymes Report 2009 | 4 Feb 2010 |
| Group financial statement for 2009 | 21 Jan 2010 |